Literature DB >> 7962028

The effect of osteogenin (a bone morphogenetic protein) on the formation of bone in orthotopic segmental defects in rats.

S Stevenson1, N Cunningham, J Toth, D Davy, A H Reddi.   

Abstract

We studied the effects of partially purified, natural osteogenin, a bone morphogenetic protein, on the formation of bone in rats. An osteoperiosteal segmental defect, eight millimeters wide, in the middle of the femoral diaphysis was created bilaterally in thirty-six adult male Fischer rats and stabilized with a polyacetyl plate and threaded Kirschner wires. One defect was filled with a cylinder of 60 per cent hydroxyapatite and 40 per cent tricalcium phosphate ceramic (pore diameter, 250 to 400 micrometers) containing 100 micrograms of partially purified bovine osteogenin, and the contralateral defect was filled with a hydroxyapatite-tricalcium ceramic cylinder without osteogenin. Eighteen animals (six animals each at one, two, and four months after the operation) were studied histologically and histomorphometrically. The implants from eighteen additional animals (six animals each at one, two, and four months after the operation) were subjected to biomechanical testing. Histomorphometry revealed that the total area of bone, the area of bone outside of the implant, and the amount of bone within the pores of the implant were all significantly (p < or = 0.05) greater in the femora that had an implant with osteogenin than in those that had an implant without osteogenin at most time-periods. The presence of osteogenin had no significant effect on the biomechanical parameters measured in this study.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7962028     DOI: 10.2106/00004623-199411000-00011

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  9 in total

1.  Osteogenic protein-1 delivered by hydroxyapatite-coated implants improves bone ingrowth in extracortical bone bridging.

Authors:  Neil Saran; Renwen Zhang; Robert E Turcotte
Journal:  Clin Orthop Relat Res       Date:  2010-09-28       Impact factor: 4.176

Review 2.  Cell-free and cell-based approaches for bone regeneration.

Authors:  Ericka M Bueno; Julie Glowacki
Journal:  Nat Rev Rheumatol       Date:  2009-11-10       Impact factor: 20.543

Review 3.  Biomaterial delivery of morphogens to mimic the natural healing cascade in bone.

Authors:  Manav Mehta; Katharina Schmidt-Bleek; Georg N Duda; David J Mooney
Journal:  Adv Drug Deliv Rev       Date:  2012-05-22       Impact factor: 15.470

4.  Long-term safety and efficacy of human bone morphogenetic protein (HBMP) in the treatment of resistant non-unions and failed arthrodesis.

Authors:  Arya Nick Shamie; Hamed Yazdanshenas; Eric Egan Johnson
Journal:  J Clin Orthop Trauma       Date:  2016-11-16

5.  Effect of Escherichia coli-produced recombinant human bone morphogenetic protein 2 on the regeneration of canine segmental ulnar defects.

Authors:  Yasuji Harada; Takamasa Itoi; Shigeyuki Wakitani; Hiroyuki Irie; Michiko Sakamoto; Dongwei Zhao; Yoshinori Nezu; Takuya Yogo; Yasushi Hara; Masahiro Tagawa
Journal:  J Bone Miner Metab       Date:  2011-11-02       Impact factor: 2.626

6.  Enhancement of bone ingrowth in a titanium fiber mesh implant by rhBMP-2 and hyaluronic acid.

Authors:  S Itoh; M Matubara; T Kawauchi; H Nakamura; S Yukitake; S Ichinose; K Shinomiya
Journal:  J Mater Sci Mater Med       Date:  2001-07       Impact factor: 3.896

7.  OP-1 augments glucocorticoid-inhibited fracture healing in a rat fracture model.

Authors:  Robert S Gilley; Larry J Wallace; Craig A Bourgeault; Louis S Kidder; Joan E Bechtold
Journal:  Clin Orthop Relat Res       Date:  2009-03-20       Impact factor: 4.176

8.  Antibody-Mediated Osseous Regeneration for Bone Tissue Engineering in Canine Segmental Defects.

Authors:  A Khojasteh; S Hosseinpour; M M Dehghan; F Mashhadiabbas; M Rezai Rad; S Ansari; S Farzad Mohajeri; H H Zadeh
Journal:  Biomed Res Int       Date:  2018-02-28       Impact factor: 3.411

9.  Bone formation in a rat tibial defect model using carboxymethyl cellulose/BioC/bone morphogenic protein-2 hybrid materials.

Authors:  Sang-Heon Song; Young-Pil Yun; Hak-Jun Kim; Kyeongsoon Park; Sung Eun Kim; Hae-Ryong Song
Journal:  Biomed Res Int       Date:  2014-04-06       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.